Similar Papers

Paper Title
Journal
Date
Author
Identification of a novel recombinant allele, HLA-DPB1*835:01:01:02, in Black South African individuals.
Shayne Loubser ... Dhriti Sengupta
HLA | VOL. 94
Shayne Loubser, et. al.Shayne Loubser ... Dhriti Sengupta
16 Sep 2019
CXCR6 gene characterization in two ethnically distinct South African populations and association with viraemic disease control in HIV-1-infected black South African individuals
Anabela C.P Picton ... Caroline T Tiemessen
Clinical Immunology | VOL. 180
Anabela C.P Picton, et. al.Anabela C.P Picton ... Caroline T Tiemessen
18 Apr 2017
C03 A CIS-acting modifier of age at diagnosis of huntington disease in black south african patients
Jessica Levesley ... Darren G Monckton
-
Jessica Levesley, et. al.Jessica Levesley ... Darren G Monckton
01 Sep 2018
JC Virus and APOL1 Risk Alleles in Black South Africans With Hypertension-Attributed CKD
Nolubabalo U Nqebelele ... Saraladevi Naicker
Kidney International Reports | VOL. 4
Nolubabalo U Nqebelele, et. al.Nolubabalo U Nqebelele ... Saraladevi Naicker
17 May 2019
View more papers

More From: HLA

Paper Title
Journal
Date
Author
Identification of the Novel HLA-DRB3*02:213 Allele by Next-Generation Sequencing.
Charlène Bouthemy ... Nicolas Congy-Jolivet
HLA | VOL. 105
Charlène Bouthemy, et. al.Charlène Bouthemy ... Nicolas Congy-Jolivet
01 Feb 2025
The Novel HLA-A*02:1195N Null Allele Identified by Next-Generation Sequencing.
Justine Schmitt ... André Gothot
HLA | VOL. 105
Justine Schmitt, et. al.Justine Schmitt ... André Gothot
01 Feb 2025
Identification of Two Novel Alleles HLA-B*14:136 and HLA-B*58:159 by Next-Generation Sequencing.
Qingdong Guan ... Hernan Suniga
HLA | VOL. 105
Qingdong Guan, et. al.Qingdong Guan ... Hernan Suniga
01 Feb 2025
Characterisation of the Novel HLA-A*29:200N Allele by Sequencing-Based Typing.
Thibault Pajot ... Myriam Labalette
HLA | VOL. 105
Thibault Pajot, et. al.Thibault Pajot ... Myriam Labalette
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.